ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 69 filers reported holding ALBIREO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $321,000 | -74.7% | 16,052 | -59.2% | 0.00% | -100.0% |
| Q2 2019 | $1,269,000 | +8.1% | 39,356 | +8.0% | 0.00% | 0.0% |
| Q1 2019 | $1,174,000 | +29.3% | 36,448 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $908,000 | -28.4% | 37,018 | -3.8% | 0.00% | 0.0% |
| Q3 2018 | $1,269,000 | +1.5% | 38,489 | +9.3% | 0.00% | 0.0% |
| Q2 2018 | $1,250,000 | – | 35,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |